Elkins Park, PANCT06839482Now EnrollingIRB Ready

Stroke Clinical Trial in Elkins Park, PA

Access cutting-edge stroke treatment through this clinical trial at a research site in Elkins Park. Study-provided care at no cost to qualified participants.

Sponsored by IRCCS San Raffaele Roma

Quick Self-Assessment

See if you qualify for this Elkins Park location

Preparing your pre-screening questions…

Expert Care in Elkins Park

Access stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke treatment provided free

Apply for This Elkins Park Location

Check if you qualify for this stroke clinical trial in Elkins Park, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Elkins Park

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Elkins Park site if eligible
  4. 4Begin participation

About This Stroke Study in Elkins Park

This multicenter international randomized controlled trial (RCT) evaluates the effectiveness of the Gloreha Sinfonia® robotic exoskeleton for upper limb rehabilitation in individuals with subacute post-stroke paresis. The study aims to determine whether robotic-assisted therapy improves voluntary motor control and coordination more effectively than conventional rehabilitation, as measured by the Fugl-Meyer Assessment (FMA) for the upper limb (motor component). Participants will be randomly assigned to one of two groups: * Experimental Group (EG): Robotic-assisted upper limb rehabilitation combined with conventional therapy. * Control Group (CG): Conventional therapy alone including upper limb rehabilitation. Clinical assessments will be conducted at baseline (T1), post-treatment (T2), and at a 3-month follow-up (T3) using remotely administered scales. Secondary objectives include evaluating improvements in muscle strength, range of motion, eye-hand coordination, manual dexterity, and functional independence. The study will also assess prognostic factors influencing response to robotic therapy, patient satisfaction, and potential adverse events.

Sponsor: IRCCS San Raffaele Roma

Who Can Participate

Inclusion Criteria

Age 18-90 years
Paresis of the upper limb following a recent cerebrovascular event (subacute ischemic or hemorrhagic stroke)
Moderate to mild muscle weakness in the thumb opponens, common finger flexors, and wrist flexors, assessed with complete joint movement in absence of gravity, Medical Research Council Scale (MRC) ≥ 2
Time from acute event \<90 days
Ability to understand and sign the study informed consent
Ability to perform study procedures.

Exclusion Criteria

Presence of other overlapping neurological disorders
Presence of osteoarticular or neuromuscular disorders affecting upper limb mobility
Severe psychiatric disorders
Severe cognitive (MMSE ≤ 17) and/or language impairment compromising exercise comprehension
Botulinum toxin injection in the affected upper limb within the last 60 days or planned during the study and follow-up period
Open wounds, infections, or unprotected skin lesions on the upper limb
Severe spasticity of the upper limb (biceps and wrist and finger flexors) (MAS \> 3)
Inability to adhere to the exercise program due to low compliance
Participants who have not signed the informed consent for the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Elkins Park?

Yes, this clinical trial (NCT06839482) has an active research site in Elkins Park, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Treatment Options in Elkins Park, PA

If you're searching for stroke treatment options in Elkins Park, PA, this clinical trial (NCT06839482) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Elkins Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Elkins Park, PA

See all stroke clinical trials recruiting in Elkins Park — not just this study.

Browse Stroke Trials in Elkins Park →

Browse More Trials by Condition

Ready to Join in Elkins Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Elkins Park, PA